|
| Total effect improvement group (n = 83) | Group with no improvement in overall effect (n = 166) | P |
| Sex, number of cases (%) |
|
| 0.266 |
| male | 56 (67.5) | 100 (60.2) |
|
| female | 27 (32.5) | 66 (39.8) |
|
| Age, number of cases (%) |
|
| 0.909 |
| Less than 3 years old | 16 (19.3) | 34 (20.5) |
|
| 3 - 6 years old | 27 (32.5) | 60 (36.1) |
|
| 6 - 12 years old | 24 (28.9) | 44 (26.5) |
|
| 12 - 18 years old | 16 (19.3) | 28 (16.9) |
|
| Body weight (kg), mean ± SD | 21.22 ± 11.99 | 19.71 ± 11.01 | 0.323 |
| Hemoglobin value before blood transfusion (g/L), mean ± standard deviation | 52.77 ± 9.73 | 53.73 ± 9.44 | 0.453 |
| Hemoglobin value after infusion (g/L), mean ± standard deviation | 86.98 ± 16.53 | 71.66 ± 14.53 | <0.001 |
| Malignant disease, cases (%) |
|
| 0.509 |
| Yes | 52 (62.7) | 111 (66.9) |
|
| No | 31 (37.3) | 55 (33.1) |
|
| Type of red blood cell suspension infused, number of cases (%) |
|
| 0.084 |
| Red blood cell suspension | 78 (94.0) | 144 (86.7) |
|
| Wash red blood cell suspension | 5 (6.0) | 22 (13.3) |
|
| Whether there is fever before infusion, number of cases (%) |
|
| 0.659 |
| Yes | 16 (19.3) | 36 (21.7) |
|
| No | 67 (80.7) | 130 (78.3) |
|
| Whether blood transfusion is timely, number of cases (%) |
|
| 0.625 |
| timely | 71 (85.5) | 138 (83.1) |
|
| delay | 12 (14.5) | 28 (16.9) |
|
| No fever before blood transfusion, fever after blood transfusion, cases (%) |
|
| <0.001 |
| Yes | 64 (95.5) | 98 (75.4) |
|
| No | 3 (4.5) | 32 (24.6) |
|